Stay updated on DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.

Latest updates to the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page
- Check4 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2; removed the 'Back to Top' link. No other substantive changes (pricing, stock, or time-slot information).SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific drug information related to Lanadelumab and the inclusion of new facility and location details, while removing previous location references.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.